Teladoc Health Inc (TDOC)
12.72
+0.27
(+2.17%)
USD |
NYSE |
May 14, 15:19
Teladoc Health Enterprise Value: 2.553B for May 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 13, 2024 | 2.553B |
| May 10, 2024 | 2.468B |
| May 09, 2024 | 2.517B |
| May 08, 2024 | 2.511B |
| May 07, 2024 | 2.626B |
| May 06, 2024 | 2.611B |
| May 03, 2024 | 2.609B |
| May 02, 2024 | 2.645B |
| May 01, 2024 | 2.614B |
| April 30, 2024 | 2.604B |
| April 29, 2024 | 2.712B |
| April 26, 2024 | 2.648B |
| April 25, 2024 | 2.702B |
| April 24, 2024 | 2.770B |
| April 23, 2024 | 2.772B |
| April 22, 2024 | 2.697B |
| April 19, 2024 | 2.639B |
| April 18, 2024 | 2.673B |
| April 17, 2024 | 2.666B |
| April 16, 2024 | 2.665B |
| April 15, 2024 | 2.736B |
| April 12, 2024 | 2.848B |
| April 11, 2024 | 2.914B |
| April 10, 2024 | 2.897B |
| April 09, 2024 | 2.991B |
| Date | Value |
|---|---|
| April 08, 2024 | 2.917B |
| April 05, 2024 | 2.895B |
| April 04, 2024 | 2.854B |
| April 03, 2024 | 2.881B |
| April 02, 2024 | 2.868B |
| April 01, 2024 | 2.956B |
| March 31, 2024 | 2.998B |
| March 28, 2024 | 2.972B |
| March 27, 2024 | 2.966B |
| March 26, 2024 | 2.929B |
| March 25, 2024 | 2.934B |
| March 22, 2024 | 2.921B |
| March 21, 2024 | 2.967B |
| March 20, 2024 | 2.989B |
| March 19, 2024 | 2.926B |
| March 18, 2024 | 2.941B |
| March 15, 2024 | 2.941B |
| March 14, 2024 | 2.894B |
| March 13, 2024 | 2.944B |
| March 12, 2024 | 2.982B |
| March 11, 2024 | 3.019B |
| March 08, 2024 | 2.991B |
| March 07, 2024 | 2.979B |
| March 06, 2024 | 2.850B |
| March 05, 2024 | 2.819B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.468B
Minimum
May 10 2024
44.90B
Maximum
Feb 08 2021
11.67B
Average
6.170B
Median
Enterprise Value Benchmarks
| Omnicell Inc | 1.460B |
| Phreesia Inc | 1.156B |
| 10x Genomics Inc | 2.857B |
| Biote Corp | 205.46M |
| American Shared Hospital Services | 29.64M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -81.89M |
| Revenue (Quarterly) | 646.13M |
| Total Expenses (Quarterly) | 723.21M |
| EPS Diluted (Quarterly) | -0.49 |
| Gross Profit Margin (Quarterly) | 69.89% |
| Profit Margin (Quarterly) | -12.67% |
| Earnings Yield | -11.08% |
| Normalized Earnings Yield | -9.730 |